|65.80||-0.20 / -0.30%|
As of Apr 24
|66.46||+0.66 / +1.00%|
The 17 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 70.00, with a high estimate of 80.00 and a low estimate of 55.00. The median estimate represents a +6.38% increase from the last price of 65.80.
The current consensus among 23 polled investment analysts is to Hold stock in Bristol-Myers Squibb. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.